Attenuation of GVHD for allo-bone marrow transplantation recipient by fasL-fas pathway in an H-2 haplotype disparate mouse combination
- 37 Downloads
In order to explore a new special and effective way to prevent, graft versus, host disease (GVHD) after allogenic bone marrow transplantation (alle-BMT), the stem cell antigen-1 (Sea-1) carly hematopoietic cells (EHC) from BALB/c mouse (H-2d) were introduced with exogenous mouse Fas ligand (mFasL) cDNA gene by the retrevirus-mediated gene transfer and expanded for one week, and then they were co-cultured with the spleen mononuclear cells (SMNC) from BAC mouse (H-2d, h) as one way mixed lymphocyte reaction (OWMLR). The cytotoxicity of treated BAC mouse SMNC against Na2 51CrO4 labeling SMNC from BALB/c mouse was observed. The bone marrow mononuclear cells (BMMNC) from BAC mouse treated by the above methods were transplanted into lethally-irradiated congenic BALB/c mice to observe the occurrence of GVHD. The results showed that the SMNC from BAC mouse after OWMLR with exogenous mFasL cDNA gene-transduced hematopoietic cells (HC) from BALB/c mouse in a ratio of 1 to 5 exhibited an obvious inhibition of the cytotoxicity against the BALB/c mouse spleen cells at different effector/target ratios as compared to the control group (P<0.01). The grade I GVHD or no GVHD and the 80% survival rate at day 60 post-BMT were observed in the BALB/c mouse receiving BAC mouse BMMNC treated with similar way, while the grade II–III GVHD and the 20% survival rate were noted in the control group (P<0.01). It is suggested that the attenuation of GVHD in allo-BMT recipient could be successfully achieved through FasL-Fas pathway in an H-2 haplotype disparate mouse combination.
Key wordsFas ligand Fas allogenic bone marrow transplantation graft versus host disease
Unable to display preview. Download preview PDF.
- 6.Ba D N. Application of Current Immunological Techniques (Chinese). Beijing: Publishing House of Beijing Medical University and China Union Medical University, 1998 172–215.Google Scholar
- 7.Cavazzana-Calvo M, Stephan J L, Samacki Set al. Attenuation of graft-versus-host disease and graft rejection byEx Vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination. Blood. 1994, 83(1): 283Google Scholar
- 9.He C M, Shi B Y. Immunology of Organ Transplantation (Chinese. Beijing: Publishing House of People’s Military Medicine. 1995, 268–283.Google Scholar
- 11.Austin T W, Salimi S, Veres Get al. Long-term multilineage expression in peripheral blood from a Moloney murine leukemia virus vector after serial transplantation of transduced bone marrow cells. Blood, 1999, 95: 829Google Scholar
- 14.Li J Z, Wang H L, Han Z C. Experimentology, of Blood (Chinese). Shanghai: Shanghai Publishing House of Science and Technology, 1997, 62: 622.Google Scholar